News
Migraine and Contraceptives
AHS doctors discuss the contraindication of contraceptives for women with migraine with aura
Migraine & Stroke Risk in Women
Hans-Christoph Diener, MD, PhD expands on stroke risks specific to women with migraine with aura.
CGRP-Blocking Antibodies: Q&A With Dr. David Dodick
Emerging treatments, such as calcitonin gene-related peptide (CGRP)-blocking antibodies, hope to put an end to migraine. Dr. David Dodick explains how and why they work.
From The Journal: Direct and Indirect Costs of Migraine
New research provides a contemporary estimate of the true cost of migraine
Introducing the Migraine Center of Excellence
The American Headache Society and Medscape announce collaboration on a new resource for the treatment of migraine
Tension-type headache found to have significant association with white matter hyperintensities
In January, the British Medical journal published an article by Adelborg and colleagues which showed that patients with migraine are more likely to have cardiovascular disease, venous thromboembolism, atrial fibrillation and atrial flutter.
Long Wait Time for Headache Specialty Care?
Headache is a common reason that patients seek out medical care. It is the fifth most common reason for emergency department (ED) visits and accounts for more than 10 million physician visits annually.
Migraine with Aura, Contraceptives and Stroke Risk
From the Journal: Risk of stroke associated with use of estrogen containing contraceptives in women with migraine: A systematic review
From the Journal: Less Cortical Thickness in Patients with Persistent Post-Traumatic Headache Compared to Healthy Controls
Post-traumatic headache is one of the most common symptoms patients experience during concussion recovery. When these headaches persist for longer than three months, they are classified as Persistent Post-Traumatic Headache (PPTH).
The Role of Catastrophizing in Pediatric Migraine
Concordance or discordance in pain catastrophizing between parents and children may impact pain coping in children with migraine, according to a study presented by Grace Tunning
New migraine drugs have promise — and a $8,500 price tag
A promising new group of drugs, named after calcitonin gene-related peptide (CGRP), a neurotransmitter tied to migraine, has changed that. CGRP drugs are being developed both to prevent migraines before they happen, and to stop attacks once they occur.
New Migraine Drugs On The Horizon
There are exciting advancements on the horizon in the area of treating and preventing migraine headaches. In the U.S. a host of new drugs are in the final stages of approval and testing.
Rebecca Erwin Wells: Member Spotlight
Dr. Wells believes in a team-based approach to care and empowering providers to fight headache stigma